1 |
interleukin-2
(14120 times)
|
Allergy and Immunology (4911 times)
|
IFN-gamma (1526 times) NK (1151 times) TNF-alpha (956 times)
|
1980 Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.
|
2 |
cytokines--interleukin 2
(4 times)
|
Environmental Health (1 time)
|
IFN-gamma (3 times) TNF-alpha (2 times) Con A (1 time)
|
1994 Differential nm23 gene expression at the fetal-maternal interface.
|
3 |
interleukin-2 receptor
(4 times)
|
Pathology (1 time)
|
ATL (1 time) BALF (1 time) DBP (1 time)
|
1990 Activation antigens in patients with Sjogren's syndrome.
|
4 |
antibody-interleukin 2
(3 times)
|
Science (2 times)
|
EpCAM (1 time) GM-CSF (1 time) mGM-CSF (1 time)
|
1996 Eradication of human hepatic and pulmonary melanoma metastases in SCID mice by antibody-interleukin 2 fusion proteins.
|
5 |
interleukin-2 therapy
(3 times)
|
Neoplasms (1 time)
|
ALC (1 time) CPI (1 time) irAEs (1 time)
|
2002 [Two cases of renal cell carcinoma with ascites after interleukin-2 therapy].
|
6 |
Interleukine-2
(3 times)
|
Pharmacology (1 time)
|
Con A (1 time) CsA (1 time) CypA (1 time)
|
1988 [Effect of combined transfer of irradiated allo-lymphocytes and LAK cells on pulmonary metastasis of mammary carcinoma (SST-2) in SHR rats].
|
7 |
intra-lesional interleukin-2
(3 times)
|
General Surgery (3 times)
|
RECIST (1 time)
|
2011 Intra-lesional interleukin-2 for the treatment of in-transit melanoma.
|
8 |
DAB389-interleukin-2
(2 times)
|
Biochemistry (1 time)
|
AEs (1 time) CR (1 time) CTCL (1 time)
|
1993 Structure/function analysis of the transmembrane domain of DAB389-interleukin-2, an interleukin-2 receptor-targeted fusion toxin. The amphipathic helical region of the transmembrane domain is essential for the efficient delivery of the catalytic domain to the cytosol of target cells.
|
9 |
IL-2 complexes
(2 times)
|
Microbiology (1 time)
|
BM (1 time) BMT (1 time) HSV-1 (1 time)
|
2016 IL-2/alpha-IL-2 Complex Treatment Cannot Be Substituted for the Adoptive Transfer of Regulatory T cells to Promote Bone Marrow Engraftment.
|
10 |
interleukin-2 levels
(2 times)
|
Biochemistry (2 times)
|
I-V (1 time) OMP (1 time) P. mirabilis (1 time)
|
1998 Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions.
|
11 |
A-induced lymphoproliferation, interleukin-2
(1 time)
|
Allergy and Immunology (1 time)
|
DEX (1 time) gamma-IFN (1 time)
|
1993 Dexamethasone suppresses T cell-mediated immunity and enhances disease susceptibility to Eimeria mivati infection.
|
12 |
alpha-interleukin 2
(1 time)
|
Reproductive Medicine (1 time)
|
IFN-gamma (1 time) NK (1 time) PMA (1 time)
|
2002 Cytokine production in natural killer cells and lymphocytes in pregnant women compared with women in the follicular phase of the ovarian cycle.
|
13 |
anti-CD20-interleukin 2
(1 time)
|
Hematology (1 time)
|
ADCC (1 time) FACS (1 time) ICK (1 time)
|
2005 An anti-CD20-IL-2 immunocytokine is highly efficacious in a SCID mouse model of established human B lymphoma.
|
14 |
Egr1-Nab2-interleukin-2
(1 time)
|
Cell Biology (1 time)
|
---
|
2019 Differential Interleukin-2 Transcription Kinetics Render Mouse but Not Human T Cells Vulnerable to Splicing Inhibition Early after Activation.
|
15 |
factors-interleukin-2
(1 time)
|
Pharmacology (1 time)
|
2hPBG (1 time) AST (1 time) BMI (1 time)
|
2018 Relations of hepatic steatosis with liver functions, inflammations, glucolipid metabolism in chronic hepatitis B patients.
|
16 |
I-IL-2
(1 time)
|
Allergy and Immunology (1 time)
|
BBB (1 time) IL (1 time) Th (1 time)
|
2004 Permeability of the mouse blood-brain barrier to murine interleukin-2: predominance of a saturable efflux system.
|
17 |
IGIFR expression and conversely, exposure of the 2D6
(1 time)
|
Allergy and Immunology (1 time)
|
IGIF (1 time) IGIFR (1 time)
|
1997 A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma.
|
18 |
IL-2 enhanced MLTR
(1 time)
|
General Surgery (1 time)
|
S.I (1 time)
|
1987 [Breast cancer-specific immunity evaluated by a new in vitro method--IL-2 enhanced MLTR].
|
19 |
IL-2 mAb
(1 time)
|
Science (1 time)
|
T-regs (1 time)
|
2006 Selective stimulation of T cell subsets with antibody-cytokine immune complexes.
|
20 |
IL-2 MS
(1 time)
|
Neurosurgery (1 time)
|
---
|
2003 Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
|
21 |
IL-2 mutein, IL-2M
(1 time)
|
Biological Science Disciplines (1 time)
|
---
|
2020 Dynamic changes in the regulatory T-cell heterogeneity and function by murine IL-2 mutein.
|
22 |
IL-2 on induction of lymphokine
(1 time)
|
Neoplasms (1 time)
|
KHF (1 time) s.c (1 time)
|
1989 Enhancement of therapeutic effect of interleukin-2 on spontaneous pulmonary metastases of Lewis lung carcinoma by killer helper factor associated with increased induction of killer activity.
|
23 |
IL-2 priming
(1 time)
|
Neoplasms (1 time)
|
MSC (1 time)
|
2015 Transcriptional profiling of interleukin-2-primed human adipose derived mesenchymal stem cells revealed dramatic changes in stem cells response imposed by replicative senescence.
|
24 |
IL-2 receptor
(1 time)
|
Neoplasms (1 time)
|
Ts (1 time)
|
1991 Suppressor function of lymphocytes activated in in vitro co-culture against autologous tumor cells and expanded in interleukin-2.
|
25 |
IL-2 Site7
(1 time)
|
Allergy and Immunology (1 time)
|
---
|
2013 Methylation of IL-2 promoter at birth alters the risk of asthma exacerbations during childhood.
|
26 |
IL-2 solution
(1 time)
|
Allergy and Immunology (1 time)
|
DC (1 time) IL-2 micelle (1 time)
|
2014 Combination therapy with dendritic cell vaccine and IL-2 encapsulating polymeric micelles enhances intra-tumoral accumulation of antigen-specific CTLs.
|
27 |
IL-2, GM-CSF and TNF-alpha, and at least one of them
(1 time)
|
Allergy and Immunology (1 time)
|
PWM (1 time) PWM-RBC (1 time)
|
1993 Human T lymphocyte activation by pokeweed mitogen induces production of TNF-alpha and GM-CSF and helper signaling by IL-1 and IL-6 results in IL-2-dependent T cell growth.
|
28 |
IL-2-L
(1 time)
|
Allergy and Immunology (1 time)
|
---
|
1988 The construction and characterization of a biologically active recombinant IL-2 containing a lysine-rich C-terminal extension.
|
29 |
IL-2-producing cells
(1 time)
|
Allergy and Immunology (1 time)
|
CTL-P (1 time) MLC (1 time) SC (1 time)
|
1988 Dynamics of cytotoxic T lymphocyte precursors in vivo assessed by change in the radiation sensitivity. Evidence for development of radiation-sensitive memory cells without clonal expansion.
|
30 |
IL-2/Fc fusion
(1 time)
|
Medicine (1 time)
|
NGs (1 time) TCR (1 time)
|
2020 Regulatory T cells engineered with TCR signaling-responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter.
|
31 |
IL-2: or TNF immunotherapy
(1 time)
|
Health Services (1 time)
|
NO (1 time) TNF (1 time)
|
1996 Prevention of cytokine-induced hypotension in cancer patients by the pineal hormone melatonin.
|
32 |
IL-2Lys20
(1 time)
|
Neoplasms (1 time)
|
---
|
1991 Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL-2 cDNA.
|
33 |
IL-2MAB602
(1 time)
|
Neoplasms (1 time)
|
IL-12 (1 time)
|
2015 Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation.
|
34 |
IL-2R alpha, IL-2R beta-chain
(1 time)
|
Transplantation (1 time)
|
---
|
2000 Quantitative flow cytometry to measure the TNF-alpha and IL-2 system after heart transplantation.
|
35 |
IL-2R gamma
(1 time)
|
Allergy and Immunology (1 time)
|
SCID (1 time)
|
1996 Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression.
|
36 |
Il-2rgamma
(1 time)
|
Medicine (1 time)
|
FAH (1 time) HBV (1 time) HCV (1 time)
|
2010 Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment.
|
37 |
in vitro long-term interleukin-2
(1 time)
|
Allergy and Immunology (1 time)
|
mAb (1 time) NK (1 time) VCAM-1 (1 time)
|
1996 Expression and function of alpha 4/beta 7 integrin on human natural killer cells.
|
38 |
including lectins, interleukin-2
(1 time)
|
Allergy and Immunology (1 time)
|
mAbs (1 time) PHA (1 time)
|
1989 Potentiation of interleukin-2 production and its binding by monoclonal antibodies to the gangliosides GD3 and GD2.
|
39 |
including tumor necrosis factor (TNF-alpha),interleukin-2
(1 time)
|
Physiology (1 time)
|
COS (1 time) FGSCs (1 time) MVH (1 time)
|
2017 [Effects of COS on promoting the pathological ovarian aging mice ovarian function by regulating immune function].
|
40 |
inflammatory factor-2
(1 time)
|
Neoplasms (1 time)
|
CD31 (1 time) EOC (1 time) ITGbeta1 (1 time)
|
2017 Inhibition effect of triptolide on human epithelial ovarian cancer via adjusting cellular immunity and angiogenesis.
|
41 |
interleukin-2 and -6
(1 time)
|
Psychopharmacology (1 time)
|
HC (1 time) PANSS (1 time) SCH (1 time)
|
2009 Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics.
|
42 |
interleukin-2 antagonists
(1 time)
|
Transplantation (1 time)
|
AZA (1 time) MMF (1 time)
|
2008 Influence of immunosuppressive regimens on short-term morbidity and mortality in heart transplantation.
|
43 |
interleukin-2 heterozygous
(1 time)
|
Allergy and Immunology (1 time)
|
DSS (1 time)
|
2005 Reduced susceptibility to dextran sulphate sodium-induced colitis in the interleukin-2 heterozygous (IL-2) mouse.
|
44 |
interleukin-2 proteins
(1 time)
|
Allergy and Immunology (1 time)
|
NK (1 time) PBMC (1 time)
|
1985 Comparison of the biological activities of human recombinant interleukin-2(125) and native interleukin-2.
|
45 |
interleukin-2-activated
(1 time)
|
Allergy and Immunology (1 time)
|
PRV (1 time) SLA (1 time)
|
1998 Establishment and characterization of porcine cytolytic cell lines and clones.
|
46 |
Interleukin-2/T-cell growth factor
(1 time)
|
Pharmacology (1 time)
|
CTL (1 time)
|
1985 Modulation of in vitro cellular immune response by histamine agonists or antagonists in murine species.
|
47 |
interleukins 2, 6 and 8
(1 time)
|
Pulmonary Medicine (1 time)
|
IFN-gamma (1 time) IL-12 (1 time) TNF-alpha (1 time)
|
1995 Functions of T-cell subsets and cytokines in mycobacterial infections.
|
48 |
intraperitoneally every 12 hours for 28 days; group IB
(1 time)
|
General Surgery (1 time)
|
LAK (1 time)
|
1990 Adoptive immunotherapy of human pancreatic cancer with lymphokine-activated killer cells and interleukin-2 in a nude mouse model.
|
49 |
intraperitoneally with PBMC+Interleukin-2
(1 time)
|
Neoplasms (1 time)
|
NK (1 time)
|
2016 Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells.
|
50 |
INTRODUCTION: Low-dose interleukin-2
(1 time)
|
Physical and Rehabilitation Medicine (1 time)
|
IQR (1 time) LN (1 time)
|
2021 Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis.
|
51 |
ISIL in 20% PDLG
(1 time)
|
Biochemistry (1 time)
|
ISFI (1 time) ISILs (1 time) NMP (1 time)
|
2011 A novel injectable in situ forming poly-DL-lactide and DL-lactide/glycolide implant containing lipospheres for controlled drug delivery.
|
52 |
PHA-induced lymphokine--interleukin 2
(1 time)
|
Allergy and Immunology (1 time)
|
IFN-gamma (1 time) mAbs (1 time) PMNC (1 time)
|
1988 Fenoterol effects on the in vitro immune response.
|
53 |
PspA-interleukin-2
(1 time)
|
Allergy and Immunology (1 time)
|
GM-CSF (1 time) IgG1 (1 time) PspA (1 time)
|
1998 Enhanced protective antibody responses to PspA after intranasal or subcutaneous injections of PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2.
|
54 |
ribavirin-interleukin-2
(1 time)
|
Gastroenterology (1 time)
|
HCV (1 time) IFN-alpha (1 time)
|
2006 Pilot study of interferon-alpha-ribavirin-interleukin-2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus genotype 1.
|
55 |
scFv-Fc-interleukin 2
(1 time)
|
Pharmacology (1 time)
|
ADCC (1 time)
|
2007 Efficient growth inhibition of ErbB2-overexpressing tumor cells by anti-ErbB2 ScFv-Fc-IL-2 fusion protein in vitro and in vivo.
|